AI Earnings Predictions for Butterfly Network Inc. (BFLY)

EX-99.1

2 bfly-20260730xexx991.htm

EX-99.1

Document

Exhibit 99.1

Butterfly Network Reports Second Quarter 2026 Financial Results

Delivered Record Revenue and Adjusted EBITDA Loss Above Guidance

•Raised full year Revenue and Improved Adjusted EBITDA Guidance

•Delivered quarterly Revenue of $32.6 million in Q2, representing 39% YoY growth

•Delivered 71% Gross Margin, up 770 bps

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE) -- Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced financial results for the second quarter ended June 30, 2026, and provided a business update.

Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, "Butterfly delivered another outstanding quarter, exceeding the high end of our guidance while achieving record revenue, gross margin and adjusted EBITDA. Just as important, the world got to see what Ultrasound-on-Chip™ is capable of as two Embedded partners unveiled entirely new applications being built on our platform. It's an exciting milestone for Butterfly and a validation of the opportunity we've believed in for years."

DeVivo continued, "As those announcements captured global attention, they also highlighted something bigger: Butterfly has evolved into a multi-engine growth company. Our semiconductor platform is expanding into new markets through Butterfly Embedded; our POCUS business is building a larger enterprise opportunity through software, medical education and government; and Home & Community Care is transitioning from pilot to commercialization. Together, these growth engines reinforce one another and continue to expand our long-term opportunity."

Recent Operational and Strategic Highlights:

•Butterfly Embedded™: Added two new partners to the Embedded portfolio, totaling 11 partners, with Midjourney and Aleph Neuro unveiling the groundbreaking applications they’re building with Butterfly's Ultrasound-on-Chip™ platform.

•Compass AI™ and Enterprise Momentum: Signed six new enterprise software agreements and expanded the Compass AI software pipeline meaningfully year over year.

•FedRAMP Progress: Received provisional authorization to sell across the U.S. Department of Veterans Affairs and remains on track to achieve FedRAMP certification in the third quarter of 2026.

•Medical Education Expansion: Closed four additional medical education partners in the quarter, including entering a long-term strategic partnership with VCOM to support and gain insights following physicians from medical school to residency and clinical practice.

•Butterfly Garden™: Added a new partner focused on precision needle-guidance AI and expect three existing partner tools to become commercially available by year-end.

•Home & Community Care: Prepared for first commercial implementation in the second half of 2026, with revenue expected in the fourth quarter.

•International Expansion: Received regulatory authorization in Brazil, opening one of the world's largest and fastest-growing ultrasound markets.

Three Months Ended June 30, 2026 Financial Results

Revenue: Total revenue was $32.6 million, representing growth of 39% from $23.4 million in the second quarter of 2025. U.S. revenue was $27.6 million, up 57% from prior year, primarily driven by revenue from our Butterfly

Embedded™ partnerships, including our co-development partnership with Midjourney, as well as increased probe sales volume to our health system, medical school, and eCommerce customers. International revenue decreased 14% year-over-year to $5.0 million, largely resulting from decreased probe sales to our international distribution partners during the second quarter, although this decrease was partially offset by our recent commercial expansion into the Brazilian medical device market.

Gross margin: Gross profit was $23.3 million versus gross profit of $14.9 million in the prior year period. Gross margin increased to 71.4% compared to 63.7% in the prior year period. This increase was primarily due to the relatively higher margin return on our Butterfly Embedded™ licensing revenue, as compared to our core business offerings, as well as a reduction in software amortization costs for our historic software development investments.

Operating expenses: Operating expenses were $37.0 million, up 19% from $31.0 million in the prior year period. Total operating expenses excluding stock-based compensation and other expenses were $26.3 million, compared to $23.1 million in the second quarter of 2025, largely reflecting increased headcount in the current year from investments we've made in our internal capabilities throughout the past 12 months to support revenue growth as well as our product and software development projects.

Net loss: Net loss was $12.9 million, compared to $13.8 million in the prior year period.

Adjusted EBITDA: Adjusted EBITDA loss was $1.4 million, an

EX-99.1

2 bfly-20260430xexx991.htm

EX-99.1

Document

Exhibit 99.1

Butterfly Network Reports First Quarter 2026 Financial Results

Delivered Revenue Above Consensus and Beat Adjusted EBITDA Guidance

•Reaffirmed full year Revenue and Adjusted EBITDA Guidance

•Delivered quarterly Revenue of $26.5 million in Q1, representing 25% YoY growth.

•Delivered 69% Gross Margin up 600 bps and Adjusted EBITDA of ($6.1M) up 32% YoY

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE) -- Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced financial results for the first quarter ended March 31, 2026, and provided a business update.

Joseph DeVivo, Butterfly’s President, Chief Executive Officer and Chairman commented, “Butterfly opened the year with another strong quarter, coming in above consensus with 25% revenue growth and continued gross margin improvement. We are executing with discipline while continuing to invest in the vast opportunity ahead.”

DeVivo continued, “Our business is starting to come together around three growth engines. Point-of-care ultrasound is scaling globally. Home & Community Care is extending that capability into the patient environment. And Butterfly Embedded is expanding our technology beyond medical ultrasound into new modalities. These are not separate opportunities. They are all part of the same Butterfly platform, a single system that is beginning to work together and compound over time. We are still early, but the direction is clear, and we are building with focus and discipline to drive long-term growth.”

Recent Operational and Strategic Highlights:

•Gestational Age AI Tool: Received FDA clearance and initiated rollout of blind-sweep AI tool for rapid fetal age estimation across U.S. and global health markets.

•Butterfly Garden Ecosystem: Added two new partners, bringing the portfolio total to 30, while continuing to progress toward additional commercial-ready applications.

•Compass AI™ and Enterprise Momentum: Closed first enterprise deal of the year and drove significant growth in the software pipeline since launching the next generation Compass AI solution.

•Global Market Expansion: Advancing entry into new markets across the Americas and Asia, including high-growth regions such as Brazil, with iQ3 expansion in multiple countries.

•Home & Community Care: Progressing toward first commercial agreement in the first half of 2026, with initial statewide deployment expected in the third quarter.

•Butterfly Embedded™: Signed ninth company to the portfolio as of April 2026 and made meaningful development progress with existing partners.

•Apollo Platform Development: Continued advancement of next-generation semiconductor architecture designed to significantly increase data processing and compute performance.

Three Months Ended March 31, 2026 Financial Results

Revenue: Total revenue was $26.5 million, representing growth of 25% from $21.2 million in the first quarter of 2025. U.S. revenue was $21.4 million, up 25% from prior year, primarily driven by revenue from our Butterfly Embedded™ partnerships, including our co-development partnership with Midjourney. International revenue increased 23% year-over-year to $5.2 million, largely resulting from increased probe sales in the current year to

our distribution partners. Both our U.S. and international revenue also benefited from favorable shifts in our product sales mix towards our higher-priced iQ3 probes.

Gross margin: Gross profit was $18.3 million versus gross profit of $13.4 million in the prior year period. Gross margin increased to 68.9% compared to 63.0% in the prior year period. This increase was primarily due to the relatively higher margin return on our Butterfly Embedded™ licensing revenue, as compared to our core business offerings, as well as a reduction in software amortization costs for our historic software development investments.

Operating expenses: Operating expenses were $32.2 million, up 1% from $31.8 million in the prior year period. Total operating expenses excluding stock-based compensation and other expenses were $26.2 million, compared to $24.9 million in the first quarter of 2025, largely reflecting increased headcount in the current year from investments we've made in our internal capabilities throughout the past 12 months to support revenue growth as well as higher professional services costs.

Net loss: Net loss was $12.7 million, compared to $14.0 million in the prior year period.

Adjusted EBITDA: Adjusted EBITDA loss was $6.1 million, compared to $9.1 million in the prior year period.

EPS: EPS was $(0.05), compared to $(0.06) in the prior year period.

Adjusted EPS: Adjusted EPS was $(0.03), compared to $(0.04) in the prior year period.

Cash and cash equivalents: Cash and cash equivalents were $138.0 million as of March 31, 2026.

Guidance

Reaffirmed revenue guidance and

EX-99.1

2 bfly-20260226xexx991.htm

EX-99.1

Document

Exhibit 99.1

Butterfly Network Reports Fourth Quarter 2025 Financial Results

Delivered Record Annual and Quarterly Revenue

•Reported quarterly record Revenue of $31.5 million in Q4, representing 41% YoY growth

•Generated positive net cash flow of $6.3 million in Q4 and lowest annual cash usage in company history

•Midjourney partnership contributed $6.8 million of revenue in Q4, advancing Butterfly Embedded™ platform strategy

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE) -- Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update.

Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “Our fourth quarter 2025 performance shows that our strategy is taking hold and our vision is becoming tangible. We delivered record quarterly revenue of $31.5 million, growing 41% year over year, and achieved the first quarter of positive operating cash flow in our company’s history. Nearly two years into our strategic plan, we are executing with financial discipline, strengthening our core point-of-care business, and now realizing material organic revenue from new initiatives.”

DeVivo continued, “Butterfly is transitioning from a medical device company into a transformative semiconductor-based company building the foundation for programmable, AI-native imaging and sensing. From expanding enterprise adoption in point-of-care, to building HomeCare into a commercial business, to enabling entirely new applications through Butterfly Embedded, it’s all powered by the same proprietary Ultrasound-on-Chip™ technology. One platform and one diversified strategy that puts us in a strong position to execute and win.”

Recent Operational and Strategic Highlights:

•Butterfly Embedded™ Brand: centralized semiconductor co-development activities under the Butterfly Embedded brand, positioning Ultrasound-on-Chip™ as a long-term value driver for the company.

•Midjourney Partnership: co-development partnership with Midjourney contributed $6.8 million in Q4 revenue, as part of a larger agreement disclosed in a Form 8-K in November 2025, which details up to $74 million in expected payments to Butterfly over a five-year term.

•Compass™ AI: next generation enterprise software launch in the fourth quarter supported business with existing accounts and enterprise pipeline growth.

•Cloud and Government Authorizations: achieved GovRAMP and TX-RAMP in the U.S., strengthening Butterfly’s ability to serve federal and Department of Defense markets.

•Butterfly Garden Program: announced plan to release Butterfly’s proprietary digital 3D beam steering API to third parties, furthering the ability to develop new AI-enabled image acquisition applications.

•HomeCare Commercialization: anticipates finalizing its first commercial HomeCare agreement by mid-2026, with revenue contributions forecasted as early as late 2026 and into 2027.

•R&D Roadmap Advancement: moved the fifth-generation P5.1 chip into production and advanced Apollo development, expected to significantly increase data rate and compute performance for next-generation AI-enabled imaging and partner applications.

Three Months Ended December 31, 2025 Financial Results

Revenue: Total revenue was $31.5 million, representing growth of 41% from $22.4 million in the fourth quarter of 2024. U.S. revenue was $26.8 million, up 55% from prior year, driven by revenue from our new co-development partnership with Midjourney as well as increased probe sales in the current year. International revenue decreased 6% year-over-year to $4.7 million, largely resulting from increased sales in the prior year to then-new distribution partners.

Gross margin and adjusted gross margin: Gross profit was $21.2 million versus $13.7 million in the prior year period, and adjusted gross profit was $21.3 million versus $13.7 million in the prior year period. Total gross margin, on a GAAP basis, increased to 67.3% from 61.4% in the prior year period, and adjusted gross margin increased to 67.5% from 61.4% in the prior year period. This increase in both GAAP gross margin and adjusted gross margin was primarily due to the relatively higher margin return on our Butterfly Embedded licensing revenue, as compared to our core business offerings, as well as a reduction in software amortization costs for our historic software development investments.

Operating expenses: Operating expenses were $37.9 million, up 22% from $31.0 million in the prior year period. Total operating expenses excluding stock-based compensation and other expenses were $26.2 million, compared to $25.4 million in the fourth quarter of 2024, reflecting some of the investments we made in 2025 in our sales force and client experience func